Find information on thousands of medical conditions and prescription drugs.

Hypoxia

Home
Diseases
A
B
C
D
E
F
G
H
Hairy cell leukemia
Hallermann Streiff syndrome
Hallux valgus
Hantavirosis
Hantavirus pulmonary...
HARD syndrome
Harlequin type ichthyosis
Harpaxophobia
Hartnup disease
Hashimoto's thyroiditis
Hearing impairment
Hearing loss
Heart block
Heavy metal poisoning
Heliophobia
HELLP syndrome
Helminthiasis
Hemangioendothelioma
Hemangioma
Hemangiopericytoma
Hemifacial microsomia
Hemiplegia
Hemoglobinopathy
Hemoglobinuria
Hemolytic-uremic syndrome
Hemophilia A
Hemophobia
Hemorrhagic fever
Hemothorax
Hepatic encephalopathy
Hepatitis
Hepatitis A
Hepatitis B
Hepatitis C
Hepatitis D
Hepatoblastoma
Hepatocellular carcinoma
Hepatorenal syndrome
Hereditary amyloidosis
Hereditary angioedema
Hereditary ataxia
Hereditary ceroid...
Hereditary coproporphyria
Hereditary elliptocytosis
Hereditary fructose...
Hereditary hemochromatosis
Hereditary hemorrhagic...
Hereditary...
Hereditary spastic...
Hereditary spherocytosis
Hermansky-Pudlak syndrome
Hermaphroditism
Herpangina
Herpes zoster
Herpes zoster oticus
Herpetophobia
Heterophobia
Hiccups
Hidradenitis suppurativa
HIDS
Hip dysplasia
Hirschsprung's disease
Histoplasmosis
Hodgkin lymphoma
Hodgkin's disease
Hodophobia
Holocarboxylase...
Holoprosencephaly
Homocystinuria
Horner's syndrome
Horseshoe kidney
Howell-Evans syndrome
Human parvovirus B19...
Hunter syndrome
Huntington's disease
Hurler syndrome
Hutchinson Gilford...
Hutchinson-Gilford syndrome
Hydatidiform mole
Hydatidosis
Hydranencephaly
Hydrocephalus
Hydronephrosis
Hydrophobia
Hydrops fetalis
Hymenolepiasis
Hyperaldosteronism
Hyperammonemia
Hyperandrogenism
Hyperbilirubinemia
Hypercalcemia
Hypercholesterolemia
Hyperchylomicronemia
Hypereosinophilic syndrome
Hyperhidrosis
Hyperimmunoglobinemia D...
Hyperkalemia
Hyperkalemic periodic...
Hyperlipoproteinemia
Hyperlipoproteinemia type I
Hyperlipoproteinemia type II
Hyperlipoproteinemia type...
Hyperlipoproteinemia type IV
Hyperlipoproteinemia type V
Hyperlysinemia
Hyperparathyroidism
Hyperprolactinemia
Hyperreflexia
Hypertension
Hypertensive retinopathy
Hyperthermia
Hyperthyroidism
Hypertrophic cardiomyopathy
Hypoaldosteronism
Hypocalcemia
Hypochondrogenesis
Hypochondroplasia
Hypoglycemia
Hypogonadism
Hypokalemia
Hypokalemic periodic...
Hypoparathyroidism
Hypophosphatasia
Hypopituitarism
Hypoplastic left heart...
Hypoprothrombinemia
Hypothalamic dysfunction
Hypothermia
Hypothyroidism
Hypoxia
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Medicines

Read more at Wikipedia.org


[List your site here Free!]


Activated protein C infusion mimics antioxidant effects on hypoxia-induced microvascular injury
From CHEST, 10/1/05 by Sonja D. Bartolome

PURPOSE: Hypoxia induces an inflammatory cascade that results in injury to the microvasculature. Specifically, leukocyte adhesion to the endothelium begins, and leukocyte emigration and vascular leak follow. The mechanism of hypoxia related injury is incompletely understood, but involves oxidant stress. Infusion of antioxidants has been shown to prevent hypoxia induced microvascular injury. Activated protein C is reported to have anticoagulant and anti-inflammatory properties. Its protective role is best described during sepsis. However, it has been utilized, with some success, in experimental models of ischemic injury. Our experiments are designed to characterize the effects of activated protein C on the microvasculature during systemic hypoxia and compare them to those of a potent antioxidant, alpha-lipoic acid.

METHODS: Experiments utilize intravital microscopy of the intact rat venular bed. Five groups were utilized: saline control, activated protein C infusion alone (100mcg/kg bolus), hypoxia alone (10% O2), simultaneous hypoxia + activated protein C infusion, and hypoxia + alpha lipoic acid. Measurements of leukocyte adherence (# per 100um venule), leukocyte emigration (# per 4000 um2), and venular leak by fluorescein isothiacyanate-labeled albumin (Fi/Fo) are reported below.

RESULTS: [+ or -] SEM.

CONCLUSION: Activated protein C infusion and antioxidant infusion prevent hyploxia-related microvascular injury as evidenced by measurements of leukocyte adherence, leukocyte emigration and vascular leak.

CLINICAL IMPLICATIONS: This similarity may reflect a common mechanism of action. This work is important because the understanding of the hypoxia-induced inflammatory cascade is essential to a plethora of disease states, such as myocardial infarction, sepsis, ARDS and trauma. Further characterization of the effects of activated protein C in hypoxic injury could lead to new therapeutic use.

DISCLOSURE: Sonja Bartolome, None.

Sonja D. Bartolome MD * Alan J. Casillan John G. Wood PhD Steven Q. Simpson MD Amy R. O'Brien-Ladner MD University of Kansas School of Medicine, Kansas City, KS

COPYRIGHT 2005 American College of Chest Physicians
COPYRIGHT 2005 Gale Group

Return to Hypoxia
Home Contact Resources Exchange Links ebay